MedPath
HSA Approval

PINETARSOL SOLUTION 2.3% w/w

SIN04022P

PINETARSOL SOLUTION 2.3% w/w

PINETARSOL SOLUTION 2.3% w/w

March 20, 1990

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Licence HolderEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SOLUTION

TOPICAL

Medical Information

D05AA

焦油

Manufacturer Information

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS PTY LTD

Active Ingredients

TAR

2.3% w/w

Coal tar

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PINETARSOL SOLUTION 2.3% w/w - HSA Approval | MedPath